Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07710430 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

A Study of Leuprorelin 1-Month (4-Week) Formulation in Children With Central Precocious Puberty

StatusRecruiting
PhasePhase 4
SponsorLG Chem
Started
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. Recruitment opened
    • Study sites: 0 to 1
    v3
  2. Secondary endpoints: 5 to 6v2
  3. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
LG Chem
13 trials monitored
See 1 trial at risk
A Single-Arm, Open-Label, Multicenter, Prospective Clinical Study to Evaluate the Effectiveness and Safety of Leuprorelin 1-Month (4-Week) Formulation Administered for 24 Months in Children with Central Precocious Puberty
Trial Details
NCT Number NCT07710430
Lead Sponsor LG Chem
Conditions
(from sponsor)		 Central Precocious Puberty
Related terms Puberty, Precocious
Enrollment 43 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov